How to Prepare an Information Disclosure Statement and Keep IDS Records Accurate Across a Patent Portfolio

An information disclosure statement, or IDS, is the U.S. filing used to submit information for USPTO consideration during prosecution. At portfolio scale, accuracy comes from treating references as centrally governed records while treating every disclosure decision and IDS filing as application-specific.

A practical workflow is:

1. Capture the source event once.
2. Route it to potentially affected U.S. applications.
3. Have qualified counsel evaluate materiality against the claims in each application.
4. Prepare a compliant, application-specific filing.
5. Reconcile the filing and consideration record afterward.

This is an operational framework, not legal advice. Counsel must decide materiality, timing, and filing strategy based on the facts of each application.

Two distinctions control the workflow:

• A reference repository is not an IDS. The repository is the evidence and routing layer that supports application-specific filings.
• A family relationship is a routing signal, not proof that every related examiner considered the information. The USPTO advises practitioners not to assume that an examiner knows about other applications belonging to the same applicant or assignee. See MPEP § 2004.

What an information disclosure statement does

Under 37 CFR 1.56, individuals associated with filing and prosecution have a duty of candor and good faith that includes disclosing known information material to patentability. The duty continues for each pending claim until the claim is canceled or withdrawn, or the application is abandoned.

The rule defines materiality in terms that include information that establishes a prima facie case of unpatentability or refutes, or is inconsistent with, a position taken by the applicant. This does not mean that every reference received by a patent team must automatically be filed. Counsel must evaluate the information against the pending claims and the positions taken in that particular application.

An IDS also has important limits:

1. Filing an IDS is not a representation that a search was performed.
2. Filing an IDS is not an admission that the listed information is material to patentability. See 37 CFR 1.97(g) and (h).
3. An IDS is not permitted in a provisional application. MPEP § 609 explains that IDS practice under 37 CFR 1.97 and 1.98 applies to nonprovisional applications.

The operating rule for a portfolio is therefore: centralize the evidence, but decentralize the legal judgment by application.

How to prepare one compliant IDS

Use this five-step checklist. Counsel approval belongs at the materiality and submission decisions, not only at the final filing step.

1. Capture the information and its source

Record the information when it arrives. At a minimum, capture:

• The source document and original file
• The date received
• The person or team that received it
• The source matter, foreign application, related U.S. application, or office communication
• The document type
• A stable document identifier
• Any available translation or relevance analysis

This record should allow the team to retrieve the original document without relying on a file name or an individual’s memory.

Esgenix can help at the very start of this record. Its Intake stage turns inventor notes, transcripts and technical material into a structured invention disclosure form, and that form gives counsel a clean starting point from which the information disclosure statement for the matter can be prepared.

2. Review the information against the live claims

Counsel should evaluate the information against the claims pending in each potentially affected U.S. application. The review should account for claim amendments, prosecution positions, and the information already of record.

Do not label every foreign citation or family reference as automatically material. The same reference may require different analysis in a continuation with broad apparatus claims and a divisional with narrower method claims.

MPEP § 2004 suggests evaluating information against the broadest claims and considering whether the information is the closest information relevant to those claims. It also cautions that information should not be inaccurately or incompletely characterized.

3. Build the application-specific citation list

The IDS list must identify the application in which it is being submitted. Under 37 CFR 1.98(a)(1), each page of the list must include:

• The application number
• A space next to each document for examiner initials
• A heading that clearly identifies the submission as an information disclosure statement

U.S. patents and U.S. patent application publications must be listed separately from other documents. Each type of cited material also has identification requirements under 37 CFR 1.98(b), including patent number and issue date for U.S. patents, and publication or application details for other materials.

4. Validate copies, translations, and relevance explanations

A compliant IDS generally requires legible copies of the cited information. This includes foreign patents, publications or the portions that caused them to be listed, cited pending unpublished U.S. applications in the circumstances specified by the rule, and other information listed in the IDS.

For non-English information, 37 CFR 1.98(a)(2) and (3) requires:

• A concise explanation of the relevance as presently understood by the most knowledgeable relevant individual
• A written English translation when one is in the possession, custody, or control of, or readily available to, a relevant individual

The relevance explanation should not direct attention away from the portions that matter. MPEP § 2004 discusses the importance of reviewing foreign citations and translations carefully.

5. Use the current USPTO form and preserve filing proof

The USPTO recommends the Patent Center auto-load version of PTO/SB/08. The current USPTO forms page identifies that version as the recommended form and states that it supports citations, timing statements, timing fees, IDS size-fee assertions, and size-fee payments.

Before submission, verify the:

• Application number
• Citation list
• Attachments
• Translation and relevance-explanation requirements
• Timing basis
• IDS timing statement or fee, if required
• IDS size-fee assertion and fee, if required
• Signature and filing authorization

After submission, preserve the Patent Center receipt and the filed package. This checklist supports counsel’s review. It does not replace that review or guarantee that the USPTO will consider the submission.

Track timing and the IDS size-fee requirement separately

An accurate information disclosure statement requires more than accurate bibliographic data. The team must also select the correct procedural path for the application’s prosecution stage.

Filing situation	General procedural control
Within the early period under 37 CFR 1.97(b)	An IDS filed within three months of the relevant national application filing, or before the first Office action on the merits, can be considered without the later timing statement or timing fee. The rule also addresses national-stage and post-RCE situations.
After the early period but before final action, allowance, or another action closing prosecution	The IDS requires either the statement under 37 CFR 1.97(e) or the applicable IDS timing fee.
After those events and on or before issue-fee payment	The IDS requires both the statement under 37 CFR 1.97(e) and the applicable IDS timing fee.
IDS filed on or after January 19, 2025	Every IDS requires a written IDS size-fee assertion stating that no size fee is required or identifying the applicable fee that accompanies the filing.

The timing rules appear in 37 CFR 1.97. The USPTO’s IDS size-fee guide explains that the size-fee thresholds are based on cumulative applicant-provided or patent-owner-provided items. The thresholds are more than 50, more than 100, and more than 200 items.

The count is application-specific. A continuation or divisional starts its own count, and an RCE does not reset the count because it is not a new application. The same item listed multiple times can count multiple times. The team should verify the current USPTO fee schedule and forms on the filing date rather than relying on a stored fee value.

Use an IDS Integrity Loop across the portfolio

The following IDS Integrity Loop is an editorial operating framework, not a USPTO-mandated procedure. It separates evidence intake from legal judgment and creates a reconciliation step after filing.

Control point	Required record	Owner	Success check
Intake	Source document, receipt date, source matter, stable document ID	Docketing or operations	The original document is retrievable and is not duplicated under multiple names
Routing	Potentially affected U.S. applications, family relationship, prosecution stage	Portfolio coordinator	No application is marked cleared merely because a parent or sibling has an IDS
Decision	Counsel decision to disclose, not disclose, or investigate; short rationale; claims reviewed	Responsible attorney or agent	Each decision names the specific application and claim version
Filing	IDS list, attachments, translations or explanations, timing basis, size-fee assertion, receipt	Filing team	The filing package matches the approved decision and application number
Reconciliation	Filing receipt, documents considered or not considered, exception reason, cumulative item count	Docketing plus counsel	Exceptions create a corrective task and escalation deadline

A two-business-day intake triage can be a useful starting cadence for foreign-office communications, search reports, and developments in litigation or related applications. A monthly exception report can identify pending matters with missing documents, unresolved counsel decisions, unverified filing receipts, or unconfirmed consideration records. These are practical controls, not legal deadlines.

Worked hypothetical: one foreign citation, two U.S. matters

A European counterpart receives an examination report on June 5 citing Reference A and Reference B. The team logs the report, both references, the receipt date, and the source application once.

The routing rule identifies two pending U.S. matters:

• A continuation with broad apparatus claims
• A divisional with narrower method claims

Counsel reviews the live claims rather than relying on the family tree. Counsel decides that Reference A should be submitted in both U.S. matters. Reference B requires further review for the divisional because its relevance depends on an amended method limitation.

The coordinator then prepares separate IDS packages. For each matter, the team checks the 37 CFR 1.97 timing position, the cumulative IDS item count, the required size-fee assertion, and the required foreign-document copies and translations or relevance explanations. After filing, the team records the Patent Center receipt and later confirms whether each citation was considered or lined through.

Copying the parent IDS into every child would not provide this control. MPEP § 609.02 strongly discourages reusing completed IDS forms from other applications because the forms may contain another application number or examiner initials, which can confuse the record. A new, application-specific listing is the safer recordkeeping approach.

Common IDS integrity failures

Watch for these recurring failures:

• A foreign citation arrives but is not linked to all potentially affected U.S. applications.
• A team treats filing in a related case as proof that the current examiner considered the information.
• A non-English document lacks the required relevance explanation or an available written translation.
• The filing contains the right references but the wrong application number, timing basis, or size-fee assertion.
• The team records “filed” but never reconciles whether the USPTO considered the citations.
• A copied IDS contains examiner initials or form data from another application.

A portfolio leader should be able to select any pending U.S. application and answer, from the record:

1. What information was received?
2. Which claims and claim version were reviewed?
3. Who made the disclosure decision?
4. What was filed, and when?
5. What timing and size-fee controls applied?
6. Did the USPTO consider the cited information, or is a corrective action required?

If the record answers those questions without reconstructing events from email and memory, the portfolio has an IDS control system rather than a collection of disconnected filings.